The U.S. National Institute on Aging (NIA) awarded a firm-fixed-price purchase order contract to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The $172,938.00 contract is for maintenance service on a Simoa HD-X Analyzer used in the agency's biomedical research. The contract has a period of performance through January 11, 2029 and does not have a set-aside designation. Quanterix provides advanced instruments, assay kits, and...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $180,806 firm-fixed-price purchase order contract to Quanterix Corporation, a life sciences company that provides digital biomarker detection technology. The contract is for a SIMOA HD-X analyzer, which will replace the Institute's aging HD-1 platform and be used by the entire NIA Intramural Research Program. Quanterix has received over $30 million in prior federal contracts from...
This non-competitive purchase order for $197,979.19 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Quanterix Corporation of Billerica, Massachusetts. The firm fixed price order is for the purchase of Quanterix assay kits including the Neurology 3-Plex A Advantage Kit, pTau-181 Advantage Kit, P-Tau 231 Simoa Assay Kit, discs, buffers, and sealing oil to be used with the Simoa HD-X Analyzer currently owned by NIA. The...
This is a firm-fixed-price purchase order awarded by the National Institute of Nursing Research (NINR), a civilian agency, to Quanterix Corporation, a for-profit manufacturer of advanced biomedical equipment and research services. The $24,416.10 contract is for the supply of Quanterix's Simoa HD-X Analyzer, SR-X Biomarker Detection System, and related maintenance services. Quanterix is the prime contractor, and there are no set-aside designations mentioned. The contract award is not associated...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $107,238.60 firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer, for Simoa 4-plex 96-well plate assays to quantify serum/plasma biomarkers for Alzheimer's disease research. The assays will be used to analyze samples from participants in the Baltimore Longitudinal Study of Aging and the Genetic and Epigenetic Signatures of Translational Aging Laboratory...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a for-profit manufacturer, for the purchase of Simoa 4-plex 96-well plate assays. The assays will be used to investigate biomarkers related to Alzheimer's disease as part of the Baltimore Longitudinal Study of Aging. The potential value of the award is $197,969.40, and the completion date is December 20, 2021. This...
This is a $119,614.50 firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The award is for Quanterix's Simoa 4-plex and Singleplex 96-well Plate Assays, including reagents, buffers, and shipping, to support the NIH's biomedical research programs. This is an unset-aside, commercial...
This is a purchase order awarded by the National Institutes of Health (NIH) National Institute on Aging to Quanterix Corporation, a for-profit life sciences company, for the delivery of Simoa 4-plex assay kits and related materials. The order is valued at $39,428.06 and is for the supply of Neurology 4-Plex E assay kits, Simoa disk kits, and buffer solutions to process tau protein (p-tau 181) assays for the Baltimore Longitudinal Study of Aging (BLSA). The order does not have a set-aside...
This is a firm fixed-price service contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Quanterix Corporation, a for-profit manufacturer of digital biomarker analysis technology. The contract, valued at $15,000.00, is for Quanterix to provide Simoa detection platform instruments, assay kits, reagents, and maintenance services to support NIH research on diseases such as Alzheimer's, post-traumatic stress disorder, and infectious...
This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
The National Institute on Aging (NIA), an agency within the National Institutes of Health (NIH), awarded a firm fixed-price purchase order to Quanterix Corporation for annual maintenance support services and a warranty package for a Simoa HD-1 Analyzer. The purchase order, valued at $26,600.00, has a period of performance from May 7, 2021 to May 6, 2022. The Simoa HD-1 Analyzer is used by NIA for the Freezer Farm Quality Control project, which tests control pools of human serum and plasma to ensure the molecular integrity of proteins in biospecimens stored in the NIA Biorepository. This non-competitive acquisition was conducted as a commercial item purchase under simplified acquisition procedures, with no set-aside designation. Quanterix Corporation is a life sciences company that provides ultra-sensitive digital biomarker detection technology, including Simoa analyzers and assay kits, to federal agencies through contracts and grants.